CAS 1207113-88-9

CCG-100602

Description:

CCG-100602, with the CAS number 1207113-88-9, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential applications in cancer research. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases involved in cellular signaling pathways that regulate cell growth and proliferation. The compound is characterized by its ability to selectively inhibit these kinases, which may lead to the suppression of tumor growth in various cancer types. CCG-100602 is typically studied in vitro and in vivo to evaluate its efficacy and safety profile. Its chemical structure includes specific functional groups that contribute to its biological activity, and it is often analyzed using techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry for purity and stability assessments. As research continues, the compound may reveal further insights into its mechanism of action and potential therapeutic applications.

Formula: C₂₁H₁₇ClF₆N₂O₂

Synonyms:

• 3-Piperidinecarboxamide, 1-[3,5-bis(trifluoromethyl)benzoyl]-N-(4-chlorophenyl)-
• CCG-100602 >=98% (HPLC)
• CCG-100602
• 1-[3,5-bis(trifluoromethyl)benzoyl]-N-(4-chlorophenyl)piperidine-3-carboxamide

CCG-100602

CAS: 1207113-88-9

CCG-100602

Purity: ≥98%

Molecular weight: 478.82g/mol

Ref: 54-BUP10768

CCG-100602

CAS: 1207113-88-9

CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).

Formula: C₂₁H₁₇ClF₆N₂O₂

Purity: 99.58%

Color and Shape: Solid

Molecular weight: 478.82

Ref: TM-T22062

CCG-100602

CAS: 1207113-88-9

CCG-100602 is a small molecule inhibitor that binds to the actin filament and prevents the assembly of actin filaments. This allows for the disruption of cytoskeleton dynamics and cell lysis. CCG-100602 has been shown to be effective in reducing cellular proliferation and inducing apoptosis in cancer cells, as well as inhibiting HIV replication. The drug also decreases blood pressure, which may be due to its ability to inhibit collagen production in vascular smooth muscle cells. CCG-100602 also inhibits pro-inflammatory cytokines by binding to their receptors on the cell surface, thereby reducing inflammation. CCG-100602 is a potent inhibitor of growth factor signaling pathways and has potential therapeutic applications in regenerative medicine and wound healing.

Formula: C₂₁H₁₇ClF₆N₂O₂

Purity: Min. 95%

Molecular weight: 478.8 g/mol

Ref: 3D-HYB11388